Unknown

Dataset Information

0

On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.


ABSTRACT: Cancer is the second leading cause of death affecting nearly one in two people, and the appearance of new cases is projected to rise by >70% by 2030. To effectively combat the menace of cancer, a variety of strategies have been exploited. Among them, the development of peptide-drug conjugates (PDCs) is considered as an inextricable part of this armamentarium and is continuously explored as a viable approach to target malignant tumors. The general architecture of PDCs consists of three building blocks: the tumor-homing peptide, the cytotoxic agent and the biodegradable connecting linker. The aim of the current review is to provide a spherical perspective on the basic principles governing PDCs, as also the methodology to construct them. We aim to offer basic and integral knowledge on the rational design towards the construction of PDCs through analyzing each building block, as also to highlight the overall progress of this rapidly growing field. Therefore, we focus on several intriguing examples from the recent literature, including important PDCs that have progressed to phase III clinical trials. Last, we address possible difficulties that may emerge during the synthesis of PDCs, as also report ways to overcome them.

SUBMITTER: Vrettos EI 

PROVIDER: S-EPMC5942387 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.

Vrettos Eirinaios I EI   Mező Gábor G   Tzakos Andreas G AG  

Beilstein journal of organic chemistry 20180426


Cancer is the second leading cause of death affecting nearly one in two people, and the appearance of new cases is projected to rise by >70% by 2030. To effectively combat the menace of cancer, a variety of strategies have been exploited. Among them, the development of peptide-drug conjugates (PDCs) is considered as an inextricable part of this armamentarium and is continuously explored as a viable approach to target malignant tumors. The general architecture of PDCs consists of three building b  ...[more]

Similar Datasets

| S-EPMC6941177 | biostudies-literature
| S-EPMC5522445 | biostudies-literature
| S-EPMC5877385 | biostudies-literature
| S-EPMC5928494 | biostudies-literature
| S-EPMC7563641 | biostudies-literature
| S-EPMC4427876 | biostudies-literature
| S-EPMC3241764 | biostudies-literature
| S-EPMC3985443 | biostudies-literature
| S-EPMC3598503 | biostudies-literature
| S-EPMC555729 | biostudies-literature